Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá

Completed · Not applicable

Conditions studied: Insulinemic Response, Type 2 Diabetes (Adult Onset), Hyperglycaemia (Diabetic), Hyperlipidaemia

In brief

This randomized clinical trial aims to evaluate the effects of refined high-oleic palm oil consumption on cardiovascular risk biomarkers and insulin resistance in healthy adults. Participants will be randomly assigned to two groups to consume either high-oleic palm oil or olive oil for four months in typical domestic preparations.

Key facts

Study ID

NCT07748559

Run by

Ruby Alejandra Villamil

People needed

52

Starts

2024-10-22

Expected to finish

2026-06-02

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged ≥18 years
• Stable medication dosages (if applicable)
• Signed informed consent

You may not qualify if…

• o Use of nutritional supplements
• Uncontrolled chronic diseases (e.g., diabetes, chronic kidney disease)
• Allergies to palm oil or olive oil

Where it is running

• Pontificia Universidad Javerian — Bogotá, Colombia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.